39
Participants
Start Date
August 20, 2024
Primary Completion Date
September 30, 2028
Study Completion Date
September 30, 2028
Standard surgery
The location and size of the tumor determine the type of surgery.
CEB-01
It is novel formulation for local release of chemotherapy. It consists of a biocompatible and biodegradable nanofiber membrane made of poly(lactic-co-glycolic acid) (PLGA), which is loaded with the anti-tumor drug SN-38 and implanted in the surgical bed after tumor removal.
RECRUITING
H. Clínico San Carlos, Madrid
RECRUITING
H.U. Virgen del Rocío, Seville
RECRUITING
H. Clínico Univ. de Valencia, Valencia
RECRUITING
Hospital Clínico y Provincial de Barcelona, Barcelona
Lead Sponsor
MFAR
OTHER
CEBIOTEX
INDUSTRY